AI-Based Differential Diagnosis and Localization of Tachycardia Using ECG: Multicenter Registry (EP-AI ASSIST)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age19+
SponsorInha University Hospital

About this trial

This multicenter retrospective study aims to develop, validate, and clinically apply an artificial intelligence (AI)-powered electrocardiography (ECG) algorithm for the diagnosis and prognostic prediction of cardiovascular diseases, including coronary artery disease and heart failure. By utilizing encrypted raw 12-lead ECG text data and deep neural network models, the study evaluates the effectiveness of AI-enhanced ECG in detecting cardiac abnormalities and predicting clinical outcomes.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients aged 19 years or older diagnosed with tachycardias (including PSVT, WPW syndrome, PVC, or VT) who have undergone an electrophysiological study (EPS) and radiofrequency catheter ablation (RFCA).

Patients with 12-lead electrocardiogram (ECG) records extractable as text (XML) files.

Disqualifiers

None

Trial population

Retrospective cohort of patients diagnosed with tachycardias who underwent electrophysiological studies and catheter ablation at participating institutions\[cite: 1\].

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

  • AI-based ECG Diagnostic and Localization Algorithm

    Diagnostic test

    Application of a deep learning-based 12-lead electrocardiogram (ECG) algorithm to analyze raw text data for the differential diagnosis and localization of tachycardias, including PSVT, WPW syndrome, PVC, and VT\[cite: 1\].

Treatment groups

10,000 Participants
are divided into 1 treatment group
Group A: Cardiovascular Disease and Tachycardia Cohort1 intervention

Trial outcomes

Primary outcomes

1

Diagnostic Performance (AUC-ROC) of AI-ECG Models

Time frame
Baseline

Secondary outcomes

1

Localization Accuracy of Tachycardia Origin Sites

Time frame
Baseline

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.